End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
8
CNY
|
+7.67%
|
|
+0.50%
|
+7.82%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
4,958
|
2,600
|
3,191
|
2,980
|
7,498
|
5,511
|
Enterprise Value (EV)
1 |
4,970
|
2,684
|
3,653
|
4,304
|
9,427
|
9,204
|
P/E ratio
|
43.6
x
|
25.2
x
|
50.6
x
|
45.5
x
|
32.3
x
|
42.2
x
|
Yield
|
1.04%
|
1.99%
|
2.13%
|
1.69%
|
0.38%
|
0.54%
|
Capitalization / Revenue
|
2.01
x
|
0.86
x
|
1.24
x
|
1.36
x
|
1.86
x
|
1.33
x
|
EV / Revenue
|
2.02
x
|
0.89
x
|
1.42
x
|
1.97
x
|
2.34
x
|
2.23
x
|
EV / EBITDA
|
22.1
x
|
10.3
x
|
16.8
x
|
24.5
x
|
19.3
x
|
18.5
x
|
EV / FCF
|
140
x
|
-199
x
|
-10.1
x
|
-5.53
x
|
-8.94
x
|
-4.27
x
|
FCF Yield
|
0.71%
|
-0.5%
|
-9.87%
|
-18.1%
|
-11.2%
|
-23.4%
|
Price to Book
|
3.74
x
|
1.94
x
|
2.4
x
|
2.08
x
|
3.93
x
|
2.32
x
|
Nbr of stocks (in thousands)
|
516,977
|
516,977
|
504,166
|
504,202
|
565,866
|
593,165
|
Reference price
2 |
9.590
|
5.030
|
6.330
|
5.910
|
13.25
|
9.290
|
Announcement Date
|
4/25/18
|
4/24/19
|
4/27/20
|
4/26/21
|
2/28/22
|
4/7/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
2,465
|
3,027
|
2,575
|
2,187
|
4,021
|
4,131
|
EBITDA
1 |
224.9
|
260.2
|
218.1
|
175.6
|
487.5
|
498.3
|
EBIT
1 |
122.7
|
149.3
|
104.5
|
57.92
|
303.9
|
202.7
|
Operating Margin
|
4.98%
|
4.93%
|
4.06%
|
2.65%
|
7.56%
|
4.91%
|
Earnings before Tax (EBT)
1 |
122.2
|
121.9
|
73.02
|
74.38
|
253.3
|
127.9
|
Net income
1 |
104.6
|
105.8
|
64.72
|
66.46
|
228.3
|
135.8
|
Net margin
|
4.24%
|
3.5%
|
2.51%
|
3.04%
|
5.68%
|
3.29%
|
EPS
2 |
0.2200
|
0.2000
|
0.1252
|
0.1300
|
0.4100
|
0.2200
|
Free Cash Flow
1 |
35.39
|
-13.46
|
-360.8
|
-778.5
|
-1,055
|
-2,155
|
FCF margin
|
1.44%
|
-0.44%
|
-14.01%
|
-35.6%
|
-26.23%
|
-52.17%
|
FCF Conversion (EBITDA)
|
15.73%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
33.84%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1000
|
0.1000
|
0.1350
|
0.1000
|
0.0500
|
0.0500
|
Announcement Date
|
4/25/18
|
4/24/19
|
4/27/20
|
4/26/21
|
2/28/22
|
4/7/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
12.4
|
83.3
|
462
|
1,325
|
1,929
|
3,693
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.0551
x
|
0.32
x
|
2.119
x
|
7.543
x
|
3.957
x
|
7.412
x
|
Free Cash Flow
1 |
35.4
|
-13.5
|
-361
|
-778
|
-1,055
|
-2,155
|
ROE (net income / shareholders' equity)
|
9.62%
|
7.94%
|
4.85%
|
4.13%
|
10.7%
|
4.77%
|
ROA (Net income/ Total Assets)
|
3.36%
|
3.43%
|
2.29%
|
0.92%
|
3.11%
|
1.47%
|
Assets
1 |
3,111
|
3,087
|
2,821
|
7,221
|
7,337
|
9,255
|
Book Value Per Share
2 |
2.560
|
2.590
|
2.640
|
2.850
|
3.370
|
4.000
|
Cash Flow per Share
2 |
1.220
|
1.450
|
1.040
|
1.150
|
1.530
|
1.720
|
Capex
1 |
112
|
235
|
456
|
936
|
1,561
|
2,343
|
Capex / Sales
|
4.55%
|
7.75%
|
17.7%
|
42.79%
|
38.81%
|
56.72%
|
Announcement Date
|
4/25/18
|
4/24/19
|
4/27/20
|
4/26/21
|
2/28/22
|
4/7/23
|
|
1st Jan change
|
Capi.
|
---|
| +7.82% | 608M | | +11.65% | 63.22B | | -3.51% | 46.34B | | +13.09% | 39.97B | | +17.83% | 25.46B | | +8.37% | 18.68B | | +0.84% | 17.24B | | -20.33% | 15.81B | | +0.36% | 14.9B | | -13.32% | 13.74B |
Other Specialty Chemicals
|